Showing results (261-270 of 324) with videos related to
Sort By:
Pageof 33
Journal of Translational Medicine|July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.Journal for Immunotherapy of Cancer|October 12, 2018
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitisDaniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.Journal of Translational Medicine|September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.Oncotarget|December 13, 2017
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapyYasmin A Lyons, Sunila Pradeep, Sherry Y Wu, et al.Nature Communications|February 22, 2020
Immuno-genomic landscape of osteosarcomaChia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2012
Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapyGheath Alatrash, Elizabeth A Mittendorf, Anna Sergeeva, et al.Journal of the National Cancer Institute|December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer ImmunotherapyJodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2017
Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial controlYi An, Wen Jiang, Betty Y S Kim, et al.Cancer Discovery|March 12, 2021
Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory MelanomaCara Haymaker, Daniel H Johnson, Ravi Murthy, et al.Cell Research|July 8, 2017
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte functionYoung-Hee Lee, Natalia Martin-Orozco, Peilin Zheng, et al.Pageof 33